Ads
-
Related paper
- FORMULATION DEVELOPMENT AND OPTIMIZATION OF TELMISARTAN TABLETS EMPLOYING βCD STARCH 1500 AND SOLUPLUS
- FORMULATION DEVELOPMENT OF VALSARTAN FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN
- FORMULATION AND DEVELOPMENT OF TELMISARTAN TABLETS EMPLOYING FACTORIAL DESIGNS AND STABILITY
- FORMULATION AND EVALUATION OF LOSARTAN FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH ? OPTIMIZATION BY 23 FACTORIAL DESIGN
- ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF TELMISARTAN EMPLOYING β-CYCLODEXTRIN AND SOLUPLUS – A FACTORIAL STUDY
- ENHANCEMENT OF DISSOLUTION RATE OF TELMISARTAN BY SOLID DISPERSION IN STARCH 1500 AND SOLUPLUS ALONE AND IN COMBINATION
- OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING HPβCD, PRIMOJEL AND TWEEN 80
- Design Development and Optimization of Telmisartan’s Ternary Solid Dispersion with Its Formulation
- FORMULATION AND IN VIRTO EVALUATION OF TELMISARTAN TABLETS: INFLUENCE OF SYNTHETIC AND NATURAL BINDERS
- FORMULATION DEVELOPMENT AND OPTIMIZATION OF ZOLMITRIPTAN TABLETS BY DIRECT COMPRESSION METHOD
